Biblio
“Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.”, J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
, “Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.”, J Alzheimers Dis, vol. 67, no. 3, pp. 779-794, 2019.
, “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
, “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 54, no. 2, pp. 793-9, 2016.
, “Physical Activity for Cognitive Health: A Model for Intervention Design for People Experiencing Cognitive Concerns and Symptoms of Depression or Anxiety.”, J Alzheimers Dis, vol. 94, no. 2, pp. 781-799, 2023.
, “N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 497-503, 2016.
, “Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1119-1128, 2021.
, “Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
, “A Novel Method for Direct Assessment of Everyday Competence Among Older Adults.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1229-1238, 2017.
, “Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans.”, J Alzheimers Dis, vol. 63, no. 1, pp. 181-183, 2018.
, “Meta-Analysis of Personality Traits in Alzheimer's Disease: A Comparison with Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 2, pp. 773-787, 2018.
, “Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.”, J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.
, “Information and Communication Technologies for the Activities of Daily Living in Older Patients with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 57, no. 3, pp. 927-935, 2017.
, “Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.”, J Alzheimers Dis, vol. 62, no. 2, pp. 699-711, 2018.
, “Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 359-372, 2023.
, “Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 115-135, 2017.
, “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
, “Amyloid-β in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1309-1317, 2020.
, “Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention.”, J Alzheimers Dis, vol. 90, no. 3, pp. 989-992, 2022.
, “JAD: A Forum for Philosophy in Science.”, J Alzheimers Dis, vol. 95, no. 2, pp. 411-413, 2023.
, “From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology.”, J Alzheimers Dis, vol. 94, no. s1, pp. S87-S96, 2023.
, “Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.”, J Alzheimers Dis, vol. 70, no. s1, pp. S87-S99, 2019.
, “Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1313-1325, 2018.
,